The Food and Drug Administration approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. The company's ...

The Food and Drug Administration on Monday approved Pfizer’s RSV vaccine to protect infants by vaccinating pregnant parents, becoming the first maternal shot to reach market and offering hope of ...

A Pfizer Inc. PFE, -0.48% vaccine designed to protect babies from respiratory syncytial virus, or RSV, got a green light Monday from the U.S. Food and Drug Administration — a key milestone for ...

The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer's ...

An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...

(The Hill) – The Food and Drug Administration (FDA) on Monday approved the first vaccine meant to prevent infections in infants, with the new drug designed to be administered to pregnant mothers ...

WASHINGTON — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is notorious ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

One month after the FDA’s initial approval, the CDC voted to recommend Pfizer’s RSV vaccine for pregnant people who are ...

The US Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their ...

The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...

Health officials said Thursday the kid shots have started shipping — and reminded most everyone to get a fall flu shot too. About 2 million Americans have gotten the new COVID-19 shot in the two weeks ...